Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.04) by 100 percent. This is a 14.29 percent decrease over losses of $(0.07) per share from the same period last year.
Stifel Maintains Hold on Domino’s Pizza, Lowers Price Target to $300
Stifel analyst Chris O'Cull maintains Domino's Pizza (NYSE:DPZ) with a Hold and lowers the price target from $320 to $300.
